Journal Article Summary

The article investigates the access to medications for cardiovascular diseases and hypertension in developing countries, highlighting the importance of these medicines for long-term health management. Access to effective treatments is crucial, especially as cardiovascular diseases are a leading cause of death globally, with a significant burden in low- and middle-income countries. The study aims to assess the availability, pricing, and affordability of essential cardiovascular medications to identify gaps and areas for improvement in healthcare systems.

The researchers analyzed data from 53 countries, focusing on the inclusion of 12 specific cardiovascular and hypertension medications in national essential medicine lists. They also gathered information on the availability and prices of these medications from 84 surveys across 59 countries. The findings revealed that the average availability of these medications was about 54% in low-income countries and 60% in higher-income countries, with generic medications being more accessible than brand-name drugs. However, the costs of these medications were often unaffordable, particularly in low-income settings, where patients might need to work several days to afford a month's supply of treatment.

Despite the insights gained, the study has limitations, including the reliance on data from English-language essential medicine lists and the exclusion of certain medical technologies. Patients should be aware that just because a medication is listed as essential does not guarantee its availability or affordability in practice. It is advisable for individuals to discuss their medication options and any concerns about access with their healthcare providers, particularly in regions where these barriers are prevalent.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Husain Muhammad Jami, Datta Biplab Kumar, Kostova Deliana, Joseph Kristy T., Asma Samira, Richter Patricia, Jaffe Marc G., Kishore Sandeep P.. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2020. DOI: 10.1161/JAHA.119.015302. PMID: 32338557. PMCID: PMC7428558.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]